Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Saccharin bill passes Senate cmte.

Executive Summary

Labor & Human Resources Cmte. passed Chairman Hatch's (R-Utah) measure April 17 to extend moratorium on FDA's proposed saccharin ban. Amendment by Sen. Metzenbaum (D-Ohio) limits the moratorium extension to two years, instead of three. Another amendment offered by Metzenbaum to require labeling on aspartame-containing products to disclose the amount of aspartame contents was rejected by the cmte. Bill is expected to be considered on the Senate floor the week of April 22, the expiration date of the current moratorium.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS008218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel